Related Experiment Video
Updated: Apr 1, 2026

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Mucormycosis: what emergency physicians need to know?
1Department of Emergency Medicine, San Antonio Military Medical Center, Houston, TX 78234.
Mucormycosis is a rare but deadly fungal infection, primarily impacting immunocompromised and diabetic individuals. Early emergency department diagnosis and treatment with antifungals and surgery are crucial for improving the poor prognosis.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Emergency Medicine
Background:
- Mucormycosis is a rare fungal infection often seen in immunocompromised patients.
- It presents in various forms with a high mortality rate.
- Prompt diagnosis and treatment in the emergency department are essential.
Purpose of the Study:
- To review the diverse presentations and forms of mucormycosis.
- To outline diagnostic strategies and treatment options.
- To emphasize the importance of early recognition and management.
Main Methods:
- Literature review of mucormycosis cases and management.
- Analysis of risk factors, clinical presentations, and diagnostic modalities.
- Evaluation of treatment outcomes and prognostic indicators.
Main Results:
- Fungi causing mucormycosis are ubiquitous and angioinvasive, leading to necrosis.
- Risk factors include immunocompromised status and diabetes mellitus.
- Common forms include rhino-orbital-cerebral, pulmonary, and disseminated disease.
Conclusions:
- Physicians must maintain a high index of suspicion for mucormycosis in at-risk patients.
- Treatment involves antifungal therapy (e.g., amphotericin B) and surgical debridement.
- The prognosis for mucormycosis remains poor despite aggressive management.
More Related Videos
12:29Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
06:43Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
Published on: January 13, 2016
Related Concept Videos
Fungal Group Zygomycota
Peptic Ulcer
Antifungal Agents
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
Acute Respiratory Failure-III
Fungal Phylum Microsporidia